skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
10640476
Filing Dt:
08/14/2003
Publication #:
Pub Dt:
08/11/2005
Inventors:
Alexander William Oxford, Richard Anthony Borman, Robert Alexander Coleman et al
Title:
5-HT2B receptor antagonists
Assignment: 1
Reel/Frame:
014929/0900Recorded: 01/28/2004Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/14/2003
Exec Dt:
10/14/2003
Exec Dt:
10/29/2003
Exec Dt:
10/27/2003
Exec Dt:
11/28/2003
Assignee:
2 ORCHARD ROAD, ROYSTON
HERTFORDSHIRE, UNITED KINGDOM SG8 5HD
Correspondent:
NIXON & VANDERHYE, P.C.
B. J. SADOFF
1100 NORTH GLEBE ROAD, 8TH FLOOR
ARLINGTON, VIRGINIA 22201
Assignment: 2
Reel/Frame:
014929/0943Recorded: 01/28/2004Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/28/2003
Exec Dt:
11/28/2003
Exec Dt:
11/28/2003
Exec Dt:
12/03/2003
Exec Dt:
11/28/2003
Assignee:
2 ORCHARD ROAD, ROYSTON
HERTFORDSHIRE, UNITED KINGDOM SG8 5HD
Correspondent:
NIXON & VANDERHYE P.C.
B. J. SADOFF
1100 NORTH GLEBE ROAD, 8TH FLOOR
ARLINGTON, VA 22201
Assignment: 3
Reel/Frame:
021413/0267Recorded: 08/20/2008Pages: 2
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/09/2006
Assignee:
2 ORCHARD ROAD, ROYSTON
HERTFORDSHIRE, UNITED KINGDOM SG8 5HD
Correspondent:
B. J. SADOFF
901 NORTH GLEBE ROAD
11TH FLOOR
ARLINGTON, VA 22203

Search Results as of: 05/03/2024 07:45 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT